Galera Therapeutics Inc’s recent filing unveils that its 10% Owner Schneid Yair acquired Company’s shares for reported $25650.0 on Feb 08 ’24. In the deal valued at $0.17 per share,150,000 shares were bought. As a result of this transaction, Schneid Yair now holds 8,043,203 shares worth roughly $1.37 million.
Then, Schneid Yair bought 175,000 shares, generating $30,185 in total proceeds. Upon buying the shares at $0.17, the 10% Owner now owns 7,893,203 shares.
Before that, Schneid Yair bought 25,000 shares. Galera Therapeutics Inc shares valued at $5,025 were divested by the 10% Owner at a price of $0.20 per share. As a result of the transaction, Schneid Yair now holds 7,718,203 shares, worth roughly $1.31 million.
Piper Sandler downgraded its Galera Therapeutics Inc [GRTX] rating to a Neutral from a an Overweight in a research note published on August 10, 2023; the price target was decreased to $0.50 from $6. A number of analysts have revised their coverage, including BTIG Research’s analysts, who decreased its forecast for the stock in mid October from “a Buy” to “a Neutral”. BofA Securities also remained covering GRTX and has decreased its forecast on October 19, 2021 with a “an Underperform” recommendation from previously “Buy” rating.
Price Performance Review of GRTX
On Friday, Galera Therapeutics Inc [NASDAQ:GRTX] saw its stock jump 2.47% to $0.17. Over the last five days, the stock has gained 18.57%. Galera Therapeutics Inc shares have risen nearly 14.17% since the year began. Nevertheless, the stocks have fallen -93.36% over the past one year. While a 52-week high of $3.59 was reached on 02/28/24, a 52-week low of $0.09 was recorded on 03/28/24. SMA at 50 days reached $0.1979, while 200 days put it at $0.6173. A total of 0.43 million shares were traded, compared to the trading of 0.93 million shares in the previous session.
Levels Of Support And Resistance For GRTX Stock
The 24-hour chart illustrates a support level at 0.1583, which if violated will result in even more drops to 0.1506. On the upside, there is a resistance level at 0.1718. A further resistance level may holdings at 0.1776. The Relative Strength Index (RSI) on the 14-day chart is 41.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0322, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.99%. Stochastics %K at 22.90% indicates the stock is a holding.
How much short interest is there in Galera Therapeutics Inc?
A steep rise in short interest was recorded in Galera Therapeutics Inc stocks on Mar 15, 2024, dropping by -0.56 million shares to a total of 2.8 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 3.36 million shares. There was a decline of -20.0%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 5.20% of the overall stock float, the days-to-cover ratio (short ratio) fell to 1.26.
